علاج سرطان الرغامى في السرطان الغدي الكيسي المتقدم مع تطور ملحوظ في المرض

References

• The most common types are squamous-cell carcinoma (SCC) and adenoid cystic carcinoma (ACC), which together account for more than two-thirds of primary tracheal tumors in adults.
• Consider multi-agent chemotherapy for patients with advanced ACC exhibiting significant disease progression and symptoms [II, B].
• In patients with symptoms of advanced disease, multi-agent chemotherapy may be considered.
• Consider targeted therapies based on molecular profiling for patients with advanced tracheal tumors [III, B].
• Thus, NGS may be recommended for later lines of therapy, when standard treatment options are exhausted, and there is a need to explore targeted therapies based on the specific genetic profile of the tumor.